Form D · Biotechnology
CEMINES INC
Denver, CO · CIK 0001269297
Offering snapshot reported Jan 25, 2010 · SEC filing
- Reported sold
- $250K Offering amount: $525K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 7, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2010 | Initial | $250,000 | No comparison | 2 | SEC filing |
| Aug 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-60044
Source: Form D, filed Jan 25, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard A. Cavalli | Director |
| Bailey Dotson | Director |
| Jack Heaton | Director |
| Kenneth Kades | Director |
| Richard Pickard | Director |
| Gregory Stanislawski | Director |
| Donald B. Wingerter | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Sparkman Shaffer Perlick Llp 1616 17 Th Street, Ste. 564
Denver, CO, 80202-1278
Denver, CO, 80202-1278